8th Dec 2010 15:52
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 8 December 2010: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company has today been notified of the following share transactions entered into today by Mr Thomas Lynch, a non-executive Director and Dr Geoffrey Guy, a Director and Executive Chairman of the Company.
Mr Thomas Lynch purchased 47,665 ordinary shares of 0.1p each from Dr Geoffrey Guy. This transaction between Directors, which equates to 0.04% of the issued ordinary share capital of the company, took place at the prevailing market price of 104.9 pence per share.
Dr Guy has also today transferred 4,256 ordinary shares of 0.1p each, equating to less than 0.01% of the issued ordinary share capital of the company, into his personal pension scheme. This transaction took place at the prevailing market price of 106.75 pence per share.
Following this notification:
Mr Lynch's holding in the shares of GW Pharmaceuticals PLC is 47,665 ordinary shares, amounting to 0.04% of shares in issue.
Dr Guy retains a beneficial interest in 18,306,783 ordinary shares, amounting to 13.95% of the shares in issue.
The total number of shares outstanding in the Company is 131,243,292 ordinary shares of 0.1p each.
For further information, please contact:
GW Pharmaceuticals PLC +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt Ltd (Nominated Adviser)
James Steel/Vijay Barathan +44 (0) 207 418 8900
Related Shares:
GWP.L